Anna-Janina Behrens

Anna-Janina Behrens

Auto-generated profile, based on publicly available information

Anna-Janina Behrens

Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
MMMax Medina-Ramírez
Max Medina-Ramírez
FGFernando Garces
Fernando Garces
AEAmelia Escolano
Amelia Escolano
PSPatrick Skog
Patrick Skog
STSteven W. de Taeye
Steven W. de Taeye
RSRogier W. Sanders
Rogier W. Sanders
Induction of broadly neutralizing antibodies (bNAbs) by HIV-1 envelope glycoprotein immunogens would be a major advance toward an effective vaccine. A critical step in this process is the activation of naive B cells expressing germline (gl) antibody precursors that have the potential to evolve into bNAbs. Here, we reengineered the BG505 SOSIP.664 glycoprotein to engage gl precursors of bNAbs that target either the trimer apex or the CD4-binding site. The resulting BG505 SOSIP.v4.1-GT1 trimer binds multiple bNAb gl precursors in vitro. Immunization experiments in knock-in mice expressing gl-VRC01 or gl-PGT121 show that this trimer activates B cells in vivo, resulting in the secretion of specific antibodies into the sera. A crystal structure of the gl-targeting trimer at 3.2-Å resolution in complex with neutralizing antibodies 35O22 and 9H+109L reveals a native-like conformation and the successful incorporation of design features associated with binding of multiple gl-bNAb precursors.

14 September 2017 in Expert Review of Proteomics
Verified
Journal Article
Open access
ABAnna-Janina Behrens
Anna-Janina Behrens
WSWeston B Struwe
Weston B Struwe
MCMax Crispin
Max Crispin
Introduction: Much of the efforts to develop a vaccine against the human immunodeficiency virus (HIV) have focused on the design of recombinant mimics of the viral attachment glycoprotein (Env). The leading immunogens exhibit native-like antigenic properties and are being investigated for their ability to induce broadly neutralizing antibodies (bNAbs). Understanding the relative abundance of glycans at particular glycosylation sites on these immunogens is important as most bNAbs have evolved to recognize or evade the dense coat of glycans that masks much of the protein surface. Understanding the glycan structures on candidate immunogens enables triaging between native-like conformations and immunogens lacking key structural features as steric constraints limit glycan processing. The sensitivity of the processing state of a particular glycan to its structural environment has led to the need for quantitative glycan profiling and site-specific analysis to probe the structural integrity of immunogens. Areas covered: We review analytical methodologies for HIV immunogen evaluation and discuss how these studies have led to a greater understanding of the structural constraints that control the glycosylation state of the HIV attachment and fusion spike. Expert commentary: Total composition and site-specific glycosylation profiling are emerging as standard methods in the evaluation of Env-based immunogen candidates.

3 September 2016 in mAbs
Verified
Journal Article
Open access
JCJenny Calow
Jenny Calow
ABAnna-Janina Behrens
Anna-Janina Behrens
SMSonja Mader
Sonja Mader
UBUlrike Bockau
Ulrike Bockau
WSWeston B. Struwe
Weston B. Struwe
MCMax Crispin
Max Crispin
Antibody glycosylation is a key parameter in the optimization of antibody therapeutics. Here, we describe the production of the anti-cancer monoclonal antibody rituximab in the unicellular ciliate, Tetrahymena thermophila. The resulting antibody demonstrated enhanced antibody-dependent cell-mediated cytotoxicity, which we attribute to unusual N-linked glycosylation. Detailed chromatographic and mass spectrometric analysis revealed afucosylated, oligomannose-type glycans, which, as a whole, displayed isomeric structures that deviate from the typical human counterparts, but whose branches were equivalent to fragments of metabolic intermediates observed in human glycoproteins. From the analysis of deposited crystal structures, we predict that the ciliate glycans adopt protein-carbohydrate interactions with the Fc domain that closely mimic those of native complex-type glycans. In addition, terminal glucose structures were identified that match biosynthetic precursors of human glycosylation. Our results suggest that ciliate-based expression systems offer a route to large-scale production of monoclonal antibodies exhibiting glycosylation that imparts enhanced cell killing activity.

1 July 1996 in Microbiology
Verified
Journal Article
Open access
ABAnnett Behrens
Annett Behrens
MHMartin Heller
Martin Heller
RRRicardo Rosenbusch
Ricardo Rosenbusch
HKHelga Kirchhoff
Helga Kirchhoff
The ultrastructural distribution and immunological accessibility of the variable surface proteins VspA, VspB, VspC and VspD were determined by immunoelectron microscopy on the surface of negatively stained cells of Mycoplasma bovis PG45 and 18 subclones, expressing either one or two of the Vsps. The variable proteins VspA, VspB, VspC and VspD, recognized by two monoclonal antibodies (mAb 1E5 and mAb 87-2) and visualized by goat-anti-murine-lgM labelled with gold particles, showed identical distribution patterns on the surfaces of the cells of all M. bovis clones investigated. Gold particles were distributed over the whole cell surface, arranged in clusters. The cell form seemed not to have an influence on the decoration pattern. Gold particles were also observed in irregular distributions around the cells. All clones showed unlabelled cells as well as strongly and weakly labelled cells. There were in general, however, no significant differences in the percentages of unlabelled, weakly labelled and strongly labelled cells, either between clones expressing different Vsps or between individual clones. No correlations were found between the numbers of labelled cells in immunoelectron microscopy and the numbers of labelled colonies in immunobinding assay (IBA) originating from the same broth cultures. The percentage of positive colonies in IBA was generally much higher than the percentage of positive cells in immunoelectron microscopy. The results show that the cells of the M. bovis clones are not identical, but differ in their surface antigens, and reveal the high variable potential of this species.

30 July 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
DHDavid John Harvey
David John Harvey
ABAnna-Janina Behrens
Anna-Janina Behrens
MCMax Crispin
Max Crispin
WSWeston B. Struwe
Weston B. Struwe
Negative ion collision-induced dissociation (CID) of underivatized N-glycans has proved to be a simple, yet powerful method for their structural determination. Recently, we have identified a series of such structures with GalNAc rather than the more common galactose capping the antennae of hybrid and complex glycans. As part of a series of publications describing the negative ion fragmentation of different types of N-glycan, this paper describes their CID spectra and estimated nitrogen cross sections recorded by travelling wave ion mobility mass spectrometry (TWIMS). Most of the glycans were derived from the recombinant glycoproteins gp120 and gp41 from the human immunodeficiency virus (HIV), recombinantly derived from human embryonic kidney (HEK 293T) cells. Twenty-six GalNAc-capped hybrid and complex N-glycans were identified by a combination of TWIMS, negative ion CID, and exoglycosidase digestions. They were present as the neutral glycans and their sulfated and α2→3-linked sialylated analogues. Overall, negative ion fragmentation of glycans generates fingerprints that reveal their structural identity.